Phesgo bula
WebTrade Name (s): Phesgo ® Pertuzumab/trastuzumab/hyaluronidase is the generic name for the trade name drug Phesgo. In some cases, health care professionals may use trade name or the generic name when referring to the drug. Drug Type: Pertuzumab, trastuzumab, and hyaluronidase is a targeted therapy. WebAttachment 1 AusPAR – Phesgo SC – pertuzumab/trastuzumab - Roche Products Pty Ltd - PM-2024-01326-1-4 Final 20 September 2024. This is the Product Information that was approved with the submission described in this AusPAR. It may have been superseded. For the most recent PI, please refer to the TGA website at
Phesgo bula
Did you know?
WebNel setting neoadiuvante, Phesgo deve essere somministrato da 3 a 6 cicli in associazione con chemioterapia nell’ambito di un regime completo per il trattamento del carcinoma … WebPhesgo je indikovaný na použitie v kombinácii s docetaxelom u dospelých pacientov s HER2-pozitívnym metastatickým alebo lokálne rekurentným neresekovateľným karcinómom …
WebHODNOTIACA SPRÁVA – ODBORNÉ STANOVISKO (NA ÚČELY KATEGORIZÁCIE LIEKOV) K NÁVRHU ČÍSLO (22833, 22832) Phesgo 600 mg/600 mg; 1200mg/600 mg injekčný roztok … WebA relevância clínica do desenvolvimento de anticorpos antipertuzumabe, antitrastuzumabe ou anti-hialuronidase humana recombinante PH20 após o tratamento com Phesgo ® é …
WebPhesgo® contains pertuzumab, trastuzumab, and hyaluronidase-zzxf. It is best to read this information with our general information about breast cancer. These treatments belong to a group of targeted therapy drugs known as monoclonal antibodies. They both work by targeting specific proteins (receptors). WebPhesgo ist zur Anwendung in Kombination mit Docetaxel bei erwachsenen Patienten mit HER2-positivem metastasiertem oder lokal rezidivierendem, inoperablem Brustkrebs …
Web18. dec 2024 · We have approved your BLA for Phesgo (pertuzumab, trastuzumab, and hyaluronidase zzxf) effective this date. You are hereby authorized to introduce or deliver for introduction into interstate commerce, Phesgo, under your existing Department of Health and Human Services U.S. License No. 1048. The indications for Phesgo are listed below: 1.
WebPhesgo é indicado para utilização, em associação com quimioterapia, para o: tratamento neoadjuvante de doentes adultos com cancro da mama HER2 positivo, localmente … mountainside restaurant north conwayWebPhesgo® combined these two separate monoclonal antibodies into a single injection for use. Trastuzumab and pertuzumab are monoclonal antibodies that both target a protein … mountainside resort in stowe vermontWebPHESGO on Day 1 of the first taxane-containing cycle [see Clinical Studies (14.2)]. Metastatic Breast Cancer (MBC) When administered with PHESGO, the recommended … mountainside resort in coloradoWeb5. okt 2024 · Bulário Eletrônico Publicado em 05/10/2024 08h46 Atualizado em 11/11/2024 10h47 O objetivo do Bulário Eletrônico é facilitar o acesso rápido e gratuito pela … hearing unitedWebPhesgo ist in zwei unterschiedlichen Stärken erhältlich. Siehe Abschnitt 6 für mehr Informationen. Phesgo wird zur Behandlung von erwachsenen Patienten mit Brustkrebs … hearing \u0026 speech center of floridaWebPhesgo injektionsvæske, opl. 600+600 mg og 1200+600 mg Roche Åben/luk alle Om indlægssedlen 1. Virkning og anvendelse 2. Det skal du vide, før du begynder at bruge Phesgo 3. Sådan skal du bruge Phesgo 4. Bivirkninger 5. Opbevaring 6. Pakningsstørrelser og yderligere oplysninger Indehaver af markedsføringstilladelsen og fremstiller … mountainside resort in granby coloradoWebPhesgo VOLTAR BULA PARA PACIENTES PUBLICIDADE Informações PRODUTO Phesgo FABRICANTE Roche TIPO Biológico NECESSITA DE RECEITA Sim, necessita de Receita … mountainside road birmingham al